Institut Pasteur Korea announced that it held an international symposium under the theme of ‘100-day mission to respond to the pandemic’ at Institut Pasteur Korea located in Pangyo Techno Valley, Gyeonggi-do.
This symposium was prepared to derive key strategies, such as international cooperation and innovative technology platforms, to achieve the ‘100 Day Mission’, a global effort to prepare for future pandemics.
The ‘100 Day Mission’ aims to develop and utilize effective vaccines, treatments, and diagnostic methods within 100 days of the onset of the pandemic risk, and is supported by G7 countries, global public health organizations such as the World Health Organization (WHO), and the Coalition for Infectious Disease Innovations (CEPI). It is being promoted under the leadership of .
To this end, about 20 domestic and foreign scientific leaders who are active at the forefront of preparing for and responding to global infectious diseases had in-depth discussions in three sessions on ▲new drug development strategy roadmap ▲vaccine development and professional training ▲next-generation global R&D governance.
In particular, Dr. Kate O’Brien, WHO Director of Immunizations, Vaccines and Biologicals, Professor Stuart Cole, Director of the Pasteur Institute in France, Dr. Marie-Paul Chieny, Chairman of the International Pharmaceutical Patent Pool (MPP) and the Foundation for the Development of Drugs for Neglected Diseases (DNDi), and Jerome Kim of International Vaccines. Global experts such as the Institute’s Secretary-General, and domestic scholars in the field of infectious diseases such as National Institute of Infectious Diseases Director Jang Hee-chang, Vaccine Commercialization Technology Development Project Director Seong Baek-rin, and National Mouse Phenotype Analysis Project Director Seong Je-kyung attended as online and offline speakers.
In addition, to promote scientific exchange, a contest for excellent posters in the fields of infectious disease treatment and vaccine development, diagnosis and surveillance, and epidemiology was also held.
2022 marks the 200th anniversary of the birth of Dr. Louis Pasteur, who left behind achievements such as the rabies vaccine, anthrax vaccine, development of low-temperature sterilization methods, and proof of biogenesis, and traces his dedication to public health through excellent research and practical application of science. An exhibition introducing was also held.
Ji Young-mi, director of Institut Pasteur Korea, said, “In order to achieve the grand and inevitable goal of ‘100-day pandemic response mission,’ the global scientific community, including Korea, must actively participate, and this symposium can provide the cornerstone. “I hope that there will be,” he said. “Continuing Dr. Pasteur’s belief in public health, Institut Pasteur Korea will devote itself to infectious disease research and development while sparing no effort to integrate the expertise and innovation of domestic researchers, the Pasteur Network, and major global partners.” .”
Meanwhile, Dr. Pasteur established the first Institut Pasteur in Paris, France, in 1887, and currently, 33 institutions in 25 countries around the world, including Institut Pasteur Korea, have formed the Pasteur Network to play the role of a sentinel against new global infectious diseases. I’m doing it.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asian Innovation Hub Pangyo Techno Valley 2022’ news